What's breaking now, across thousands of outlets.
Only the lower of two tested doses of the idiopathic pulmonary fibrosis drug admilparant met the trial’s main objective, adding to analyst questions about the therapy’s prospects.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
[Capital FM] Nairobi -- Democratic Party of Kenya leader Justin Muturi has called on Health Cabinet Secretary Aden Duale to resign if he fails to account for the government's handling of an alleged…
When you think of people being exposed to occupational hazards, hairdressers don't come to mind. That may be why regulators often overlook the risks faced by people in this profession.
V felt tightness across his chest. His deepest breaths felt shallow. He sought help at an emergency department, where a resident physician found several worrying signs, including swelling of his hands…
